Plasma miR-142 predicts major adverse cardiovascular events as an intermediate biomarker of dual antiplatelet therapy

[1]  Jie Du,et al.  Circulating microRNA signature for the diagnosis of childhood dilated cardiomyopathy , 2018, Scientific Reports.

[2]  Y. Zhang,et al.  Suppression of microRNA-142-5p attenuates hypoxia-induced apoptosis through targeting SIRT7. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[3]  Mingxin Zhang,et al.  Down-regulation of microRNA-142-5p attenuates oxygen-glucose deprivation and reoxygenation-induced neuron injury through up-regulating Nrf2/ARE signaling pathway. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[4]  Kota Shimada,et al.  Plasma miRNA expression profiles in rheumatoid arthritis associated interstitial lung disease , 2017, BMC Musculoskeletal Disorders.

[5]  G. Meister,et al.  Transcriptomic profiling of platelet senescence and platelet extracellular vesicles , 2017, Transfusion.

[6]  M. Mayr,et al.  Association of MicroRNAs and YRNAs With Platelet Function. , 2016, Circulation research.

[7]  V. Figueredo,et al.  Dipstick proteinuria is an independent predictor of high on treatment platelet reactivity in patients on clopidogrel, but not aspirin, admitted for major adverse cardiovascular events , 2015, Platelets.

[8]  Wen-jie Ji,et al.  The Emerging Role of miR-223 in Platelet Reactivity: Implications in Antiplatelet Therapy , 2015, BioMed research international.

[9]  Nilesh J Samani,et al.  MicroRNAs in cardiovascular disease: an introduction for clinicians , 2015, Heart.

[10]  Weiqing Wang,et al.  Elevated circulating microRNA-122 is associated with obesity and insulin resistance in young adults. , 2015, European journal of endocrinology.

[11]  D. Voora,et al.  Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomics , 2015, Pharmacogenomics and personalized medicine.

[12]  M. Trivella,et al.  Differential Regulation of MicroRNAs in End-Stage Failing Hearts Is Associated with Left Ventricular Assist Device Unloading , 2015, BioMed research international.

[13]  Lin Wang,et al.  Upregulation of miR-142-5p in atherosclerotic plaques and regulation of oxidized low-density lipoprotein-induced apoptosis in macrophages , 2015, Molecular medicine reports.

[14]  Qiu-lin Tang,et al.  Plasma miR-122 and miR-192 as potential novel biomarkers for the early detection of distant metastasis of gastric cancer. , 2014, Oncology reports.

[15]  A. Siegbahn,et al.  ROLE OF ADMISSION CARDIAC BIOMARKERS IN RISK STRATIFICATION OF PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION: INSIGHTS FROM THE PLATELET INHIBITION AND PATIENT OUTCOMES TRIAL , 2014 .

[16]  M. Jeong,et al.  B cell translocation gene, a direct target of miR‐142‐5p, inhibits vascular smooth muscle cell proliferation by down‐regulating cell cycle progression , 2013, FEBS letters.

[17]  M. Mayr,et al.  Circulating MicroRNAs as Novel Biomarkers for Platelet Activation , 2013 .

[18]  Salil Sharma,et al.  Repression of miR-142 by p300 and MAPK is required for survival signalling via gp130 during adaptive hypertrophy , 2012, EMBO molecular medicine.

[19]  M. Tewari,et al.  MicroRNA profiling: approaches and considerations , 2012, Nature Reviews Genetics.

[20]  Jun Luo,et al.  Identification of circulating miRNA biomarkers based on global quantitative real-time PCR profiling , 2012, Journal of Animal Science and Biotechnology.

[21]  C. Cannon,et al.  Association of Proton Pump Inhibitor Use on Cardiovascular Outcomes With Clopidogrel and Ticagrelor: Insights From the Platelet Inhibition and Patient Outcomes Trial , 2012, Circulation.

[22]  Deepak L. Bhatt,et al.  Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. , 2010, Journal of the American College of Cardiology.

[23]  S. Shenouda,et al.  MicroRNA function in cancer: oncogene or a tumor suppressor? , 2009, Cancer and Metastasis Reviews.

[24]  R. Koppensteiner,et al.  Calcium-channel blockers decrease clopidogrel-mediated platelet inhibition , 2009, Heart.

[25]  Monika Belickova,et al.  Differential expression of microRNAs in hematopoietic cell lineages , 2008, European journal of haematology.

[26]  C. Sander,et al.  A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing , 2007, Cell.

[27]  D. Atar,et al.  Assessment of bleeding events in clinical trials--proposal of a new classification. , 2007, The American journal of cardiology.

[28]  Eugene Berezikov,et al.  Approaches to microRNA discovery , 2006, Nature Genetics.

[29]  D. Bartel,et al.  MicroRNAs Modulate Hematopoietic Lineage Differentiation , 2004, Science.

[30]  S. Yusuf,et al.  Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. , 2001, The New England journal of medicine.

[31]  S. Zhong,et al.  Catheter ablation restores decreased plasma miR-409-3p and miR-432 in atrial fibrillation patients. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.